search
Back to results

Navigation From Community to Clinic to Promote CRC Screening in Underserved Populations

Primary Purpose

Colorectal Cancer

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Tailored navigation
Sponsored by
Arizona State University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Colorectal Cancer focused on measuring Tailored navigation, Tailored messages

Eligibility Criteria

50 Years - 75 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

Phase I Inclusion criteria:

  • participants will be aged 50-75,
  • speak either English or Spanish,
  • live in low-income neighborhoods (including a range of race and ethnicity),
  • are due for CRC screening,
  • may be at average or high risk for CRC,
  • either will not identify a regular clinic they attend or will be registered (or identify) with one of the clinic systems engaged in our study. Those who do identify a clinic home, however, will also be encouraged to join the study as long as they are due for screening.

Phase II Inclusion criteria:

• Participants who keep their clinic appointment from Phase I will be enrolled in the study by clinic navigators and the Phase I inclusion criteria (above) will be re-confirmed.

Exclusion Criteria:

• Individuals who are compliant with CRC screening guidelines will not be eligible.

While we will not intentionally exclude any specific racial/ethnic group, our study materials are offered in Spanish and English. As such, anyone who does cannot speak, read, and write English or Spanish will not be eligible to participate in the study.

Sites / Locations

  • Arizona State University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Tailored Navigation

Control

Arm Description

Participants will receive tailored navigation phone calls to assist them with barriers in making a clinic appointment or attending the clinic. The tailored navigation intervention protocol will be used to guide individuals from an especially hard-to-reach, multicultural, and underinsured population into primary care clinics and, subsequently, track the effects of this intervention through a clinic navigation program to complete Colorectal cancer screening.

Participants in the control arm will receive phone calls to support data collection and tracking, but not receive tailored messages

Outcomes

Primary Outcome Measures

Primary Outcome is Clinic Attendance
Track outcomes of the Phase I intervention on colorectal cancer (CRC) screening test completion among low-income, multicultural Arizona residents aged 50 to 75 years who attend clinic.

Secondary Outcome Measures

The Secondary Outcome is Participant Completion of a CRC Screening Test.
Individuals receiving group classes and tailored navigation during Phase I will have higher rates of CRC screening test completion than those receiving classes only, (however this outcome will be primarily due to clinic attendance).

Full Information

First Posted
May 13, 2013
Last Updated
April 14, 2021
Sponsor
Arizona State University
Collaborators
Mayo Clinic, University of Arizona
search

1. Study Identification

Unique Protocol Identification Number
NCT01853774
Brief Title
Navigation From Community to Clinic to Promote CRC Screening in Underserved Populations
Official Title
Navigation From Community to Clinic to Promote CRC Screening in Underserved Populations
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
April 2012 (Actual)
Primary Completion Date
December 2016 (Actual)
Study Completion Date
March 31, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Arizona State University
Collaborators
Mayo Clinic, University of Arizona

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to test the effectiveness of a two-phase intervention using "community-to-clinic navigators" to guide individuals from an especially hard-to-reach, multicultural, and underinsured population into primary care clinics and, subsequently, to track effects of the intervention on completion of colorectal cancer (CRC) screening in clinics. A cost-effectiveness analysis will lay the foundation for further implementation and dissemination research. Aim 1: Test effectiveness of community group education + tailored navigation versus community group education only in increasing clinic attendance among low-income, multicultural Arizona residents, aged 50 to 75 yrs. Hypothesis 1: Individuals receiving group education classes + tailored navigation will show higher rates of clinic attendance than those receiving only group education. * As a separate critical step for those who make clinic appointments, the investigators will examine the effect on follow through to screening, using initial group assignment as a control variable in analysis. Patients making clinic appointments will receive referral for screening and tailored navigation as usual care. Aim 2: Track outcomes of the Phase I intervention on CRC screening test completion among low-income, multicultural Arizona residents aged 50 to 75 years who attend clinic. Hypothesis 2: Individuals receiving group classes and tailored navigation during Phase I will have higher rates of CRC screening test completion than those receiving classes only, (however this outcome will be primarily due to clinic attendance). Aim 3: Determine the cost-effectiveness of each phase of the interventions on increasing CRC screening completion among low-income, multicultural Arizona residents aged 50 to 75 years. Exploratory Aim 4: Examine the levels of program dissemination from community to clinic to final screenings using the RE-AIM model. Research Question 2: What is the degree of Reach, Efficacy, Adoption, Implementation, and Maintenance of the community-to-clinic navigation, and clinic-to-screening outcomes?
Detailed Description
Design overview: This study will employ a 2-phase experimental, randomized design to test a community to clinic navigation intervention: (1) to increase attendance at primary care clinics (Phase I), and (2) to track CRC screening among those who visit clinics (Phase II). The investigators will recruit non-adherent individuals from multicultural community sites in low-income zip codes in the Phoenix Arizona metropolitan area. In Phase I, community sites will be randomized to either group education (GE) or group education plus tailored navigation (GE +TN) to increase attendance at the primary care clinics. In Phase II, individuals who complete a clinic appointment (from Phase I) will then receive the standard of care (provider prompts, navigation calls to patients) in the clinic. Phase I brings individuals into the primary care system (clinic attendance), and Phase II follows them through to CRC screening completion (either stool-based or colonoscopy). An accelerated plan will be initiated for individuals identified as at high risk for CRC, referring them for colonoscopy, to realistically evaluate effects of the interventions in real-world conditions, including the range of patient risk profiles in this setting. Recruitment, intervention, and data collection materials have been developed in English and Spanish and reviewed by a Cultural Community Advisory Board (CCAB) for cultural fit across our multicultural population of low-income participants. Intervention details: Group education (Phase I): Groups will be assembled for an educational class after all baseline surveys are completed for a community site. The curriculum for the 60 minute class will include: general information on cancer risk, specific risk factors for CRC, brief review of dietary and physical activity guidelines, stool blood test: purpose, preparation, and procedures(emphasis on the fecal occult blood test-- FOBT-- and FIT test), requirements and reasons for annual testing, meaning of results, and importance of follow-up for positive tests, instructions and sample kit discussion colonoscopy discussion, preventative potential when polyps are removed, colonoscopy preparation, anesthesia, guidelines regarding use of colonoscopy as the primary screening tool for individuals at higher risk, and for those who test positive on stool-based screening will be discussed Tailored navigation (TN) Phase I: Participants randomized to the groups receiving GE + TN intervention will be called within 5 days of the completion of the class and will be encouraged to schedule an appointment at the nearby identified clinic. Trained, culturally sensitive navigators will navigate participants through their individual barriers and concerns, using the tailored set of responses from the message library (with a multi-theoretical basis) developed in the co-PI's previous research (R21CA100566;PI:Menon & R01NR8425; PI: Menon). Calls will continue, for a total of 5 within an 8-week period (or less, if attendance to clinic and/or adherence to screening are obtained). In whichever call becomes the final, Tracking Questions will be administered to assess the status of clinic attendance or reasons for not scheduling or keeping a clinic appointment (with the same data collected at the end of 8 weeks for non-navigated control group participants). Tailored navigation (TN) Phase II will utilize the full message library to assist patients to overcome barriers to care, negotiate healthcare systems, and access quality care. Within each clinic, an existing trained, staff member(or study navigator) will follow up on the patients who attend a clinic appointment. Although patient navigators vary by site, the primary role of the clinic-based navigator includes connecting patients to resources and support systems; assisting in communication with clinic providers and staff; streamlining appointments and paperwork; helping patients identify and access financial services, basic counseling on psychosocial issues such as fear, anxiety, appropriate social services; and tracking all interactions and outcomes. Our TN will cover all these components in the proposed study. Calls will continue for a total of 5 within an 8-week period. Control conditions clarification. In Phase I, participants in the control arm of the study will receive 3 calls designed to support data collection and tracking, but will not receive navigation messages. Call 1: 1-2 weeks after the initial clinic visit to verify contact information; Call 2: during weeks 5-6 to inquire if a clinic appointment was made and kept and to schedule data collection call for week 8 (Call 3). Call 3 (or earlier, if clinic was attended) will utilize the Tracking survey to document clinic attendance or reasons for non-attendance. During any call if an appointment was made and kept, the clinic name and provider visited will be documented, and the patient will be followed through Phase II. Data Collection: Eligibility status will be determined using initial screening questions. Participants who we determine to be ineligible will be thanked for their time, encouraged to continue with CRC screening annually (or on whatever schedule appropriate based on risk status, age and type of screening obtained). Those who are eligible will be administered the study consent. Consent procedures will inform participants the purpose and details of the study. Once participants are consented, they will be interviewed for baseline data collection. The demographic data to be collected at baseline and confirmed (repeated) if participants appear in clinics for Phase II include age, date of birth, gender, race, ethnicity, education, income and insurance, marital status, and number of adults and children in household. Screening history and risk status will be obtained to determine eligibility and serve as baseline CRC screening data. Questionnaires will be administered face to face by a Survey Interviewers who will ask questions and record the answers. Questionnaire administration will be distributed across three different points: 1) at baseline, 2) post-intervention, and 3) 6 month post-intervention. Data collection materials have been developed in English and Spanish and reviewed by a Cultural Community Advisory Board for cultural fit across our multicultural population of low-income participants. Data collection for cost-effectiveness analysis: Data for the cost analyses will be drawn from study and clinic records and tracked separately for each phase of the study. Navigators will keep logs of time spent to recruit sites, run the group classes and implement TN to account for salary spent for Phase I intervention and control. Phase II navigation calls will be tracked by clinic staff in contracting clinics. We will also capture the number of clinic appointments made, kept, and missed without timely cancellation and the number of each of the different types of screenings received. Sample Size: We expect to recruit and randomize 1,840 participants total, allowing 15% attrition (that is, 85% retention) for a final sample size of 1,600 participants. Approximately 266 groups of 5-7 participants will be formed, resulting in approximately 133 each in the control condition and intervention condition. Education groups will begin in staggered sessions over 46 months. Approximately 450 participants will be recruited each year to achieve total recruitment goals. Recruitment: We will recruit older adult, low-income participants in community settings in Phase I by (a) identifying previously engaged and new formal sites (churches, senior citizen centers, employers) for recruitment, (b) continuing to canvass nontraditional options (apartment complexes, neighborhood associations, barber shops/salons, areas of commerce), and (c) investigating new types of sites to reach a broader range of multicultural populations in low-income areas. Members of our Cultural Community Advisory Board (CCAB) include both lay advisors and strong community leaders and directors representing key institutions with community links. Eligibility screening will be done in a face-to-face interview and if the criteria are met the informed consent will be administered.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colorectal Cancer
Keywords
Tailored navigation, Tailored messages

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
419 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Tailored Navigation
Arm Type
Experimental
Arm Description
Participants will receive tailored navigation phone calls to assist them with barriers in making a clinic appointment or attending the clinic. The tailored navigation intervention protocol will be used to guide individuals from an especially hard-to-reach, multicultural, and underinsured population into primary care clinics and, subsequently, track the effects of this intervention through a clinic navigation program to complete Colorectal cancer screening.
Arm Title
Control
Arm Type
No Intervention
Arm Description
Participants in the control arm will receive phone calls to support data collection and tracking, but not receive tailored messages
Intervention Type
Behavioral
Intervention Name(s)
Tailored navigation
Other Intervention Name(s)
Tailored messages
Primary Outcome Measure Information:
Title
Primary Outcome is Clinic Attendance
Description
Track outcomes of the Phase I intervention on colorectal cancer (CRC) screening test completion among low-income, multicultural Arizona residents aged 50 to 75 years who attend clinic.
Time Frame
Attendance at the community educational class and 8 weeks beyond to attendance at a clinic.
Secondary Outcome Measure Information:
Title
The Secondary Outcome is Participant Completion of a CRC Screening Test.
Description
Individuals receiving group classes and tailored navigation during Phase I will have higher rates of CRC screening test completion than those receiving classes only, (however this outcome will be primarily due to clinic attendance).
Time Frame
At 3- and 6-months post clinic visit, we will collect screening data from patient self-report and medical chart reviews.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Phase I Inclusion criteria: participants will be aged 50-75, speak either English or Spanish, live in low-income neighborhoods (including a range of race and ethnicity), are due for CRC screening, may be at average or high risk for CRC, either will not identify a regular clinic they attend or will be registered (or identify) with one of the clinic systems engaged in our study. Those who do identify a clinic home, however, will also be encouraged to join the study as long as they are due for screening. Phase II Inclusion criteria: • Participants who keep their clinic appointment from Phase I will be enrolled in the study by clinic navigators and the Phase I inclusion criteria (above) will be re-confirmed. Exclusion Criteria: • Individuals who are compliant with CRC screening guidelines will not be eligible. While we will not intentionally exclude any specific racial/ethnic group, our study materials are offered in Spanish and English. As such, anyone who does cannot speak, read, and write English or Spanish will not be eligible to participate in the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
LInda K Larkey, PhD
Organizational Affiliation
Arizona State University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Arizona State University
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85048
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
19273397
Citation
Kim JH, Menon U. Pre- and postintervention differences in acculturation, knowledge, beliefs, and stages of readiness for mammograms among Korean American women. Oncol Nurs Forum. 2009 Mar;36(2):E80-92. doi: 10.1188/09.onf.e80-e92.
Results Reference
background
PubMed Identifier
35081762
Citation
Herman PM, Bucho-Gonzalez J, Menon U, Szalacha LA, Larkey L. Cost-Effectiveness of Community-to-Clinic Tailored Navigation for Colorectal Cancer Screening in an Underserved Population: Economic Evaluation Alongside a Group-Randomized Trial. Am J Health Promot. 2022 May;36(4):678-686. doi: 10.1177/08901171211068454. Epub 2022 Jan 27.
Results Reference
derived
PubMed Identifier
31676898
Citation
Menon U, Szalacha LA, Kue J, Herman PM, Bucho-Gonzalez J, Lance P, Larkey L. Effects of a Community-to-Clinic Navigation Intervention on Colorectal Cancer Screening Among Underserved People. Ann Behav Med. 2020 Apr 20;54(5):308-319. doi: 10.1093/abm/kaz049.
Results Reference
derived

Learn more about this trial

Navigation From Community to Clinic to Promote CRC Screening in Underserved Populations

We'll reach out to this number within 24 hrs